Demographic, comorbidity, concurrent drug, and opioid characteristics, among L-TOT users and L-TOT discontinuers between 2009–2019. by Qian Cai (112039)

Subjects:

Phagocytosis of SMPs by alveolar macrophages of MH-S cell line evaluated by flow cytometry. by Alejandra Barrera-Rosales (21656278)

Subjects:

Combined illusion score index across conditions (NI: Non-Illusion; NIT: Non-Illusion Tactile; MS: Multisensory; UV: Unimodal Visual). by Kirralise J. Hansford (20670869)

Subjects:

Fig 6 - by Kirralise J. Hansford (20670869)

Subjects:

Fig 5 - by Kirralise J. Hansford (20670869)

Subjects:

Fig 4 - by Kirralise J. Hansford (20670869)

Subjects:

Schematic of augmented reality system with tactile stimulator. by Kirralise J. Hansford (20670869)

Subjects:

Infographic of experimental conditions. by Kirralise J. Hansford (20670869)

Subjects:

Summary of the screened symptoms at baseline (t0) for completers (n = 160). by Anton Kurapov (11346019)

Subjects:

Summary of the program evaluation. by Anton Kurapov (11346019)

Subjects:

Changes in continuous sleep measures from pre (t1) to post (t2) intervention. by Anton Kurapov (11346019)

Subjects:

Overview over the contents of the app program divided by level [28]. by Anton Kurapov (11346019)

Subjects:

Sociodemographic information, participant flow, engagement, and compliance. by Anton Kurapov (11346019)

Subjects:

Changes in mental health symptoms after the sleep intervention (n = 160 completers). by Anton Kurapov (11346019)

Subjects:

‘Sleep2Ukraine’ study design. by Anton Kurapov (11346019)

Subjects:

Density differences between pre- and post-measurements for program completers (N = 160). by Anton Kurapov (11346019)

Subjects:

Immunogenicity assessment groups based on the primary and booster vaccination schemes and timeframe from the second or booster dose. by Rima Moghnieh (679199)

Subjects:

Principal Component Analysis (PCA) to illustrate the distribution of the significant lipid metabolites among the groups (NL, SS and MASH). by Laia Bertran (3685147)

Comparative analysis of macronutrient compositions between baseline and end of intervention (*p < 0.05, ^ns Non-significant results). by Duc Tran Quang (20564967)

Comparative analysis of caloric intake between baseline and end of intervention (*p < 0.05, ^ns Non-significant results). by Duc Tran Quang (20564967)